Establishes the medicaid generic drug competition and savings act.

Directs the department of social and health services, as the state medicaid agency, to require certain generic drug manufacturers to compete in a competitive bid process to ensure that the agency is providing medicaid recipients with quality generic products at a competitively bid low cost.